BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12580839)

  • 1. The use of clomiphene citrate/human menopausal gonadotrophins in conjunction with GnRH antagonist in an IVF/ICSI program is not a cost effective protocol.
    Mansour R; Aboulghar M; Serour GI; Al-Inany HG; Fahmy I; Amin Y
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):48-52. PubMed ID: 12580839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Good results of milder form of ovarian stimulation in an in vitro fertilization/intracytoplasmic sperm injection program.
    Grochowski D; Wołczyński S; Kuczyński W; Domitrz J; Szamatowicz J; Szamatowicz M
    Gynecol Endocrinol; 1999 Oct; 13(5):297-304. PubMed ID: 10599545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate/gonadotrophin/0.25 mg cetrorelix.
    Tavaniotou A; Albano C; Van Steirteghem A; Devroey P
    Reprod Biomed Online; 2003 Jun; 6(4):421-6. PubMed ID: 12831586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.
    Lin YH; Seow KM; Hsieh BC; Huang LW; Chen HJ; Huang SC; Chen CY; Chen PH; Hwang JL; Tzeng CR
    J Assist Reprod Genet; 2007 Aug; 24(8):331-6. PubMed ID: 17636445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study.
    Nyachieo A; Spiessens C; Chai DC; Mwenda JM; D'Hooghe TM
    Fertil Steril; 2009 Feb; 91(2):602-10. PubMed ID: 18328482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
    Farhi J; Ben-Haroush A; Lande Y; Sapir O; Pinkas H; Fisch B
    Fertil Steril; 2009 Feb; 91(2):377-82. PubMed ID: 18321490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles.
    Hwang JL; Huang LW; Hsieh BC; Tsai YL; Huang SC; Chen CY; Hsieh ML; Chen PH; Lin YH
    Hum Reprod; 2003 Jan; 18(1):45-9. PubMed ID: 12525439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
    Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
    Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer.
    Huang SY; Huang HY; Yu HT; Wang HS; Chen CK; Lee CL; Soong YK
    Taiwan J Obstet Gynecol; 2011 Dec; 50(4):432-5. PubMed ID: 22212313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonist protocol versus clomiphene in unexplained infertility: A randomized controlled study.
    Nada AM; ElSetohy KA; Banat MM; Shaheen AF
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):326-30. PubMed ID: 27343309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose application of cetrorelix in combination with clomiphene for friendly IVF: results of a feasibility study.
    Engel JB; Olivennes F; Fanchin R; Frydman N; Le Dû A; Blanchet V; Frydman R
    Reprod Biomed Online; 2003 Jun; 6(4):444-7. PubMed ID: 12831591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation?
    Kedem A; Tsur A; Haas J; Yerushalmi GM; Hourvitz A; Machtinger R; Orvieto R
    Fertil Steril; 2014 Jun; 101(6):1624-8. PubMed ID: 24680364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study.
    Lin YH; Hwang JL; Seow KM; Huang LW; Hsieh BC; Tzeng CR
    Gynecol Endocrinol; 2006 Jun; 22(6):297-302. PubMed ID: 16785154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial.
    Kyrou D; Kolibianakis EM; Fatemi HM; Tarlatzis BC; Tournaye H; Devroey P
    Fertil Steril; 2011 Nov; 96(5):1112-5. PubMed ID: 21924414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
    Orvieto R; Kruchkovich J; Rabinson J; Zohav E; Anteby EY; Meltcer S
    Fertil Steril; 2008 Jul; 90(1):228-30. PubMed ID: 17681292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could the addition of hp-hMG and GnRH antagonists modulate the response in IVF-ICSI cycles?
    Requena A; Landeras JL; Martínez-Navarro L; Calatayud C; Sánchez F; Maldonado V; Muñoz M; Fernández M; González A; López S; López R; Pacheco A; Calderón G; Martínez V
    Hum Fertil (Camb); 2010 Mar; 13(1):41-9. PubMed ID: 20384441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation].
    Kdous M; Chaker A; Bouyahia M; Zhioua F; Zhioua A
    Tunis Med; 2009 Dec; 87(12):834-42. PubMed ID: 20209851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
    Wu CX; Zhang T; Shu L; Huang J; Diao FY; Ding W; Gao Y; Wang W; Mao YD; Cui YG; Liu JY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar; 53(3):160-166. PubMed ID: 29609229
    [No Abstract]   [Full Text] [Related]  

  • 20. Low dose clomiphene citrate as a mild stimulation protocol in women with unsuspected poor in vitro fertilization result can generate more oocytes with optimal cumulative pregnancy rate.
    Ochin H; Ma X; Wang L; Li X; Song J; Meng Y; Shen J; Cui YG; Liu J
    J Ovarian Res; 2018 May; 11(1):37. PubMed ID: 29728130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.